Daprodustat Hepatic Impairment Study
Clinical trial NCT03223337 · COMPLETED
Trial details
- NCT number
- NCT03223337
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2018-08-20
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.